Verrica Pharmaceuticals Inc. Financial Ratios
VRCA|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-
Profit Margin
-1012.1%
Net Income / Revenue
Asset Turnover
0.16
Revenue / Total Assets
Equity Multiplier
-4.78
Total Assets / Equity
Profitability
Liquidity
Current Ratio
2.59
Quick Ratio
2.45
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.16
Inventory Turnover
-
Days Sales Outstanding
254 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-30.9%
+21.6pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.